Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Hyams

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Thorax|December 4, 2020
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohortDavid T Arnold, Fergus W Hamilton, Alice Milne, et al.
The Lancet Regional Health. Europe|August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort studyCatherine Hyams, Robert Challen, Elizabeth Begier, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Ejhaem|June 14, 2021
Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complicationsTosti J Mankelow, Belinda K Singleton, Pedro L Moura, et al.
Nature Communications|March 12, 2024
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort studyGenevieve I Cezard, Rachel E Denholm, Rochelle Knight, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
The Lancet. Infectious Diseases|June 26, 2021
Effectiveness of BNT162b2 and ChAdOx1 nCoV-19 COVID-19 vaccination at preventing hospitalisations in people aged at least 80 years: a test-negative, case-control studyCatherine Hyams, Robin Marlow, Zandile Maseko, et al.
The Lancet Regional Health. Europe|December 19, 2022
Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: A prospective cohort study in Bristol, United KingdomCatherine Hyams, Robert Challen, Robin Marlow, et al.
Journal of the Royal Society of Medicine|July 5, 2023
Impact of SARS-CoV-2 infective exacerbation of chronic obstructive pulmonary disease on clinical outcomes in a prospective cohort study of hospitalised adultsCatherine Hyams, George Qian, George Nava, et al.
Thorax|December 4, 2020
Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohortDavid T Arnold, Fergus W Hamilton, Alice Milne, et al.
The Lancet Regional Health. Europe|August 15, 2022
Incidence of community acquired lower respiratory tract disease in Bristol, UK during the COVID-19 pandemic: A prospective cohort studyCatherine Hyams, Robert Challen, Elizabeth Begier, et al.
BJGP Open|September 9, 2024
Estimating the burden of vaccine-preventable lower respiratory tract disease in UK primary care: protocol for a prospective surveillance study (AvonCAP GP2)Polly Duncan, Ruth Mears, Elizabeth Begier, et al.
Ejhaem|June 14, 2021
Blood group type A secretors are associated with a higher risk of COVID-19 cardiovascular disease complicationsTosti J Mankelow, Belinda K Singleton, Pedro L Moura, et al.
Nature Communications|March 12, 2024
Impact of vaccination on the association of COVID-19 with cardiovascular diseases: An OpenSAFELY cohort studyGenevieve I Cezard, Rachel E Denholm, Rochelle Knight, et al.
Pageof 5